56921
Strep B ChromoSelect Selective Agar Base
suitable for microbiology, NutriSelect® Plus
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
41171606
NACRES:
NA.85
esterilidade
non-sterile
Nível de qualidade
forma
powder
prazo de validade
limited shelf life, expiry date on the label
composição
agar, 15.0 g/L
buffers, 2.5 g/L
chromogenic mixture, 2.54 g/L
protein hydrolysate, 17.5 g/L
selective agents, 0.110 g/L
fabricante/nome comercial
NutriSelect® Plus
pH final
7.3±0.2 (25 °C)
aplicação(ões)
clinical testing
veterinary
microbiology
temperatura de armazenamento
2-8°C
adequação
Streptococcus spp.
Aplicação
Strep B ChromoSelect Selective Agar Base is recommended for selective isolation of Group B streptococci.
Nota de preparo
Suspend 37.65 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium completely. DO NOT AUTOCLAVE. Cool to 45-50°C and aseptically add the rehydrated contents of one vial of Strep B ChromoSelect Selective Supplement (Cat. No. 92650). Mix well and pour in sterile Petri plates.
Nota de rodapé
We offer two media types: the superior granulated GranuCult® and the cost-efficient powdered NutriSelect® culture media, depending on your needs.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.
The designations basic, plus, or prime are added to indicate the quality control level, from basic quality control to standard QC plus to prime for full regulatory compliance.
Informações legais
GRANUCULT is a registered trademark of Merck KGaA, Darmstadt, Germany
NutriSelect is a registered trademark of Merck KGaA, Darmstadt, Germany
Código de classe de armazenamento
13 - Non Combustible Solids
Classe de risco de água (WGK)
WGK 2
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Choose from one of the most recent versions:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 45(RR-7), 1-24 (1996-05-31)
Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections can be prevented through the use of intrapartum antimicrobial prophylaxis in women who are at increased risk for transmitting the infection to their newborns. However
B F Anthony et al.
The Journal of infectious diseases, 137(5), 524-530 (1978-05-01)
A longitudinal, three-year study of the epidemiology of group B Streptococcus was conducted with repeated (four to 11) observations of 382 patients followed through pregnancy, delivery, and the postpartum period. Group B streptococci (2.3% of which were nonhemolytic) were isolated
Murray, P.R., E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R. H. Yolken (Eds.)
Manual of Clinical Microbiology (2003)
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica